Project measures / variables set:   Xenakis1   latency_cont

ID, description, units MPD:111154   latency_cont   latency to move all four paws (extrapyramidal symptoms), placebo group   [s]  
Measures • pre-treatment    • post-treatment
Data set, strains Xenakis1   CC RIX   73 strains     sex: both     age: 7-9wks
Procedure inclined screen test
Comparisoncontrol group vs. treated group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Xenakis1 - latency to move all four paws (extrapyramidal symptoms), placebo group





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 28.0572 28.0572 0.8272 0.3638
sex 1 319.575 319.575 9.4216 0.0023
strain 42 3216.7269 76.5887 2.258 < 0.0001
group:sex 1 1.7359 1.7359 0.0512 0.8212
group:strain 42 1697.1798 40.409 1.1913 0.2031
sex:strain 42 1960.394 46.676 1.3761 0.0679
group:sex:strain 42 1164.4892 27.7259 0.8174 0.784
Residuals 327 11091.6233 33.9193

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Xenakis1 111154 inclined screen test (none) latency to move all four paws (extrapyramidal symptoms), placebo group   [s]   pre-treatment  latency_cont_pre CC RIX 72 both 7-9wks
Xenakis1 111155 inclined screen test (none) latency to move all four paws (extrapyramidal symptoms), placebo group   [s]   post-treatment  latency_cont_post CC RIX 70 both 7-9wks